hydroxyurea has been researched along with deferiprone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Datta, S | 1 |
Koussa, S; Sheikh-Taha, M; Taher, A | 1 |
Ghosh, K | 1 |
4 other study(ies) available for hydroxyurea and deferiprone
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Treatment of thalassoemia--the current scenario.
Topics: Azacitidine; Bone Marrow Transplantation; Deferiprone; Fetal Hemoglobin; Genetic Therapy; Humans; Hydroxyurea; Iron Chelating Agents; Pyridones; Thalassemia | 2002 |
Isolated thrombocytopenia associated with hydroxyurea/deferiprone (L1) therapy in a sickle beta thalassemia patient.
Topics: Adult; Antisickling Agents; beta-Thalassemia; Deferiprone; Drug Therapy, Combination; Humans; Hydroxyurea; Iron Chelating Agents; Male; Platelet Count; Pyridones; Thrombocytopenia | 2006 |
Iron chelators or therapeutic modulators of iron overload: Are we anywhere near ideal one?
Topics: Animals; beta-Thalassemia; Chelating Agents; Deferiprone; Deferoxamine; Humans; Hydroxyurea; Iron Overload; Myelodysplastic Syndromes; Transfusion Reaction | 2018 |